260 filings
S-1
FWBI
First Wave BioPharma Inc
IPO registration
31 Dec 19
5:13pm
8-K
FWBI
First Wave BioPharma Inc
30 Dec 19
Entry into a Material Definitive Agreement
5:09pm
8-K
FWBI
First Wave BioPharma Inc
20 Dec 19
Departure of Directors or Certain Officers
3:39pm
10-Q
2019 Q3
FWBI
First Wave BioPharma Inc
Quarterly report
14 Nov 19
4:31pm
8-K
FWBI
First Wave BioPharma Inc
14 Nov 19
AzurRx BioPharma, Inc. Announces Equity Purchase Agreement
9:00am
PRER14A
3au6gfwpa3ng0vkiz0eh
6 Nov 19
Preliminary revised proxy
12:00am
UPLOAD
l2upn1nrfi763f rj2
6 Nov 19
Letter from SEC
12:00am
CORRESP
sk02gxdw9a
5 Nov 19
Correspondence with SEC
12:00am
UPLOAD
japb1 qq0pmaj
4 Nov 19
Letter from SEC
12:00am
8-K
7tqwo4uuem k9
1 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
PRE 14A
fb3 4uxr6hchb
28 Oct 19
Preliminary proxy
4:35pm
8-K
nvz1u
22 Oct 19
AzurRx BioPharma CEO Issues Letter to Shareholders
3:30pm
8-K
jz68bt6
17 Oct 19
AzurRx BioPharma Announces Positive CFF DSMB Review of Final Phase 2 OPTION Trial Data
2:04pm
8-K
2heq diqrob9vyt0lnw
15 Oct 19
Regulation FD Disclosure
8:31am
8-K
x7hhpes2h7s ya7u87qd
15 Oct 19
Other Events
8:30am
8-K
3qollyev77
11 Oct 19
AzurRx BioPharma Announces Appointment of James
5:15pm
4
08y5j9 z1qdr0
10 Oct 19
AzurRx BioPharma / JAMES SAPIRSTEIN ownership change
9:11pm
3
pfba 5qjfi3v72hotjn
10 Oct 19
AzurRx BioPharma / JAMES SAPIRSTEIN ownership change
9:08pm
8-K
4j0yf9m oc104
9 Oct 19
Regulation FD Disclosure
6:03am